J. Goldman & Co’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Sell |
35,828
-29,416
| -45% | -$1.63M | 0.05% | 204 |
|
|
2025
Q1 | $3.16M | Buy |
+65,244
| New | +$3.16M | 0.08% | 168 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 337 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 347 |
|
|
2022
Q2 | – | Sell |
-81,873
| Closed | -$1.94M | – | 326 |
|
|
2022
Q1 | $1.94M | Sell |
81,873
-48,644
| -37% | -$1.15M | 0.09% | 141 |
|
|
2021
Q4 | $4.46M | Buy |
+130,517
| New | +$4.46M | 0.25% | 80 |
|
|
2021
Q3 | – | Sell |
-19,986
| Closed | -$897K | – | 339 |
|
|
2021
Q2 | $897K | Sell |
19,986
-29,593
| -60% | -$1.33M | 0.03% | 231 |
|
|
2021
Q1 | $1.28M | Buy |
49,579
+11,238
| +29% | +$291K | 0.04% | 211 |
|
|
2020
Q4 | $773K | Buy |
38,341
+15,125
| +65% | +$305K | 0.04% | 205 |
|
|
2020
Q3 | $454K | Sell |
23,216
-26,143
| -53% | -$511K | 0.03% | 187 |
|
|
2020
Q2 | $872K | Buy |
+49,359
| New | +$872K | 0.05% | 147 |
|